Satellite CME Symposia
Industry Sponsored and Satellite CME Symposia are commercially supported educational and promotional activities held in conjunction with the IASLC 2024 World Conference on Lung Cancer. The programs are approved by the IASLC as an independent activity. These programs are not supported or endorsed by the IASLC and are not part of the official IASLC ACCME accredited program.
IS05: Navigating Rapid Changes in First- and Later-Line Treatment of EGFR-Mutated NSCLC: A Practical Framework for Optimal Biomarker Testing, Treatment Selection and Sequencing, and Adverse Event Management
Room 33ABC, San Diego Convention Center
Presented by PeerView
Supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC (which are both Johnson & Johnson companies).
IS06: Do We Have Sea Change in Small Cell Lung Cancer? What Recent Clinical Trial Data Tell Us About Treatment Decision-Making in Real World Settings, What’s Next for Emerging Novel Strategies
Room 20BC, San Diego Convention Center
Presented by Physicians’ Education Resource
Supported by an educational grant from AstraZeneca.
IS09: Elevating Expectations, Broadening Impact: How to Leverage Immunotherapy and EGFR-Targeted Therapy to Improve Outcomes in Unresectable Stage III NSCLC
Room 20D, San Diego Convention Center
Presented by PeerView
Supported by an independent educational grant from AstraZeneca.
IS12: What’s Next for HER2- and Trop2-Directed ADCs in Lung Cancer: How Emerging Trial Data Will Impact Our Clinics Today and Tomorrow…
Room 20D, San Diego Convention Center
Presented by Physicians’ Education Resource
Supported by an educational grant from AstraZeneca.
IS14: Elevating Care in Resectable Stage I-III NSCLC: Targeted Therapy and Immunotherapy at the Forefront of Multimodal Treatment Strategies
Room 20D, San Diego Convention Center
Presented by PeerView
Supported by an independent educational grant from AstraZeneca.
IS15: Updating the Lung Cancer Treatment Algorithms With Novel Antibody–Drug Conjugates: Are You Prepared for Change? State of the Science, Implications for Practice, and FutureProspects
Room 20A, San Diego Convention Center
Presented by PeerView
Supported by an educational grant from Daiichi Sankyo, Inc.
IS17: Lung Cancer Tumor Board®: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
Room 30DE, San Diego Convention Center
Presented by Physicians’ Education Resource
Supported by an educational grant from Novartis Pharmaceuticals Corporation, Rigel Pharmaceuticals, Inc.
The Implications of Recent Data Sets for the Current and Future Management of Lung Cancer
Live Webcast Series
Presented by Research To Practice